Medications covered under the pilot program include pill and injectable forms of Wegovy, the Foundayo pill and the Zepbound ...

After accounting for 14% of all prescription drug spending in 2025, the blockbuster GLP-1 drug class is on track to continue rapid growth and alter pharmaceutical spending trends.  For example, Eli ...

One in five U.S. adolescents are obese, and an increasing number are being prescribed GLP-1s.

Can the new GLP-1s help prevent cancer before it starts by tackling obesity and all the dysfunctional metabolic pathways that ...

Ozempic promotes weight loss by mimicking the GLP-1 hormone the body naturally produces after eating, so users feel full for longer. This new potential therapy harnesses the power of GLP-1 while ...

Eli Lilly said its tirzepatide franchise had another stellar quarter.

Out-of-pocket costs, insurance coverage, side effects and a lack of long-term safety data can be barriers to medication for ...

Bariatric surgery leads percentage greater weight loss than GLP-1s after one year, with higher remission rates for diabetes, hypertension, ...

GLP-1 use isn't just drastically changing the lives of those, like McDonald, who are on the weight-loss drug. It's changing ...

GLP-1 shots and pills both help regulate appetite and blood sugar. Learn the differences in effectiveness, cost, and who ...

Experts describe the development of oral GLP-1 medication as a “pivotal” improvement in the accessibility and adherence to obesity drugs. As of February 2026, only Wegovy and Rybelsus are available in ...